A single-center, randomized, double-blind, placebo-controlled, parallel-group studie investigating the safety, tolerability and pharmacokinetics of single- and multiple-ascending subcutaneous doses of TA-46 in healthy volunteers - TA-46 SAD and MAD dose study to investigate safety and PK
100 项与 Therachon SAS 相关的临床结果
0 项与 Therachon SAS 相关的专利(医药)
100 项与 Therachon SAS 相关的药物交易
100 项与 Therachon SAS 相关的转化医学